酵素結合免疫吸着法(ELISA)の世界市場

◆英語タイトル:GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET 2020-2024
◆商品コード:IRTNTR41149
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年1月26日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Global Enzyme-linked Immunosorbent Assay (Elisa) Market 2020-2024Technavio has been monitoring the global enzyme-linked immunosorbent assay (elisa) market and it is poised to grow by USD 124.55 mn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our reports on global enzyme-linked immunosorbent assay (elisa) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by demand for frequent diagnostic testing for aging population.In addition, growing importance of promotional activities is anticipated to boost the growth of the global enzyme-linked immunosorbent assay (elisa) market as well.
Market Segmentation
Technavio’s global enzyme-linked immunosorbent assay (elisa) market is segmented as below:
End-user:
o Hospitals And Diagnostics Center

o Research Laboratories

o Others

Geographic Segmentation:
o North America

o APAC

o Europe

o South America

o MEA

Key Trends for global enzyme-linked immunosorbent assay (elisa) market growth
This study identifies growing importance of promotional activities as the prime reasons driving the global enzyme-linked immunosorbent assay (elisa) market growth during the next few years.
Prominent vendors in global enzyme-linked immunosorbent assay (elisa) market
We provide a detailed analysis of around 25 vendors operating in the global enzyme-linked immunosorbent assay (elisa) market, including some of the vendors such as Abbott Laboratories, Abcam Plc, Avantor Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Eppendorf AG, GlaxoSmithKline Plc, Siemens Healthineers AG and Thermo Fisher Scientific Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/enzyme-linked-immunosorbent-assay-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

Executive Summary
o Market Overview
Market Landscape
o Market ecosystem
o Value chain analysis
Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
Market Segmentation by End-user
o Market segments
o Comparison by End user placement
o Hospitals and diagnostic centers – Market size and forecast 2019-2024
o Research laboratories – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by End user
Customer landscape
o Overview
Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
Drivers, Challenges, and Trends
o Market drivers
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Volume driver – Demand shift in adjacent markets
o Price driver – Inflation
o Price driver – Shift from lower to higher priced units
o Market challenges
o Market trends
Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Abcam Plc
o Avantor Inc.
o bioMerieux SA
o Bio-Rad Laboratories Inc.
o Danaher Corp.
o Eppendorf AG
o GlaxoSmithKline Plc
o Siemens Healthineers AG
o Thermo Fisher Scientific Inc.
Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
1.Key Finding 1
2.Key Finding 2
3.Key Finding 3
4.Key Finding 4
5.Key Finding 5
6.Key Finding 6
7.Key Finding 7
8.Market in focus
9.Parent market
10.Market characteristics
11.Product / Service portfolio of key vendors included in the market definition
12.Market segments
13.Global – Market size and forecast 2019 – 2024 ($ million)
14.Global market: Year-over-year growth 2019 – 2024 (%)
15.Five forces analysis 2019 & 2024
16.Bargaining power of buyers
17.Bargaining power of suppliers
18.Threat of new entrants
19.Threat of substitutes
20.Threat of rivalry
21.Market condition – Five forces 2019
22.End user placement – Market share 2019-2024 (%)
23.Comparison by End user placement
24.Hospitals and diagnostic centers – Market size and forecast 2019-2024 ($ million)
25.Hospitals and diagnostic centers – Year-over-year growth 2019-2024 (%)
26.Research laboratories – Market size and forecast 2019-2024 ($ million)
27.Research laboratories – Year-over-year growth 2019-2024 (%)
28.Others – Market size and forecast 2019-2024 ($ million)
29.Others – Year-over-year growth 2019-2024 (%)
30. Market opportunity by End user
31.Customer landscape
32.Market share by geography 2019-2024 (%)
33.Geographic comparison
34.North America – Market size and forecast 2019-2024 ($ million)
35.North America – Year-over-year growth 2019-2024 (%)
36.Europe – Market size and forecast 2019-2024 ($ million)
37.Europe – Year-over-year growth 2019-2024 (%)
38.APAC – Market size and forecast 2019-2024 ($ million)
39.APAC – Year-over-year growth 2019-2024 (%)
40.MEA – Market size and forecast 2019-2024 ($ million)
41.MEA – Year-over-year growth 2019-2024 (%)
42.South America – Market size and forecast 2019-2024 ($ million)
43.South America – Year-over-year growth 2019-2024 (%)
44.Key leading countries
45.Market opportunity by geography ($ million)
46.Impact of drivers
47.Impact of challenges
48.Landscape disruption
49.Industry risks
50.Vendors covered
51.Market positioning of vendors
52.Abbott Laboratories – Overview (1/3)
53.Abbott Laboratories – Overview (2/3)
54.Abbott Laboratories – Overview (3/3)
55.Abbott Laboratories – Business segments
56.Abbott Laboratories – Key offerings
57.Abbott Laboratories – Key customers
58.Abbott Laboratories – Segment focus
59.Abcam Plc – Overview (1/3)
60.Abcam Plc – Overview (2/3)
61.Abcam Plc – Overview (3/3)
62.Abcam Plc – Business segments
63.Abcam Plc – Key offerings
64.Abcam Plc – Key customers
65.Abcam Plc – Segment focus
66.Avantor Inc. – Overview (1/3)
67.Avantor Inc. – Overview (2/3)
68.Avantor Inc. – Overview (3/3)
69.Avantor Inc. – Business segments
70.Avantor Inc. – Key offerings
71.Avantor Inc. – Key customers
72.Avantor Inc. – Segment focus
73.bioMerieux SA – Overview (1/3)
74.bioMerieux SA – Overview (2/3)
75.bioMerieux SA – Overview (3/3)
76.bioMerieux SA – Business segments
77.bioMerieux SA – Key offerings
78.bioMerieux SA – Key customers
79.bioMerieux SA – Segment focus
80.Bio-Rad Laboratories Inc. – Overview (1/3)
81.Bio-Rad Laboratories Inc. – Overview (2/3)
82.Bio-Rad Laboratories Inc. – Overview (3/3)
83.Bio-Rad Laboratories Inc. – Business segments
84.Bio-Rad Laboratories Inc. – Key offerings
85.Bio-Rad Laboratories Inc. – Key customers
86.Bio-Rad Laboratories Inc. – Segment focus
87.Danaher Corp. – Overview (1/3)
88.Danaher Corp. – Overview (2/3)
89.Danaher Corp. – Overview (3/3)
90.Danaher Corp. – Business segments
91.Danaher Corp. – Key offerings
92.Danaher Corp. – Key customers
93.Danaher Corp. – Segment focus
94.Eppendorf AG – Overview (1/3)
95.Eppendorf AG – Overview (2/3)
96.Eppendorf AG – Overview (3/3)
97.Eppendorf AG – Business segments
98.Eppendorf AG – Key offerings
99.Eppendorf AG – Key customers
100.Eppendorf AG – Segment focus
101.GlaxoSmithKline Plc – Overview (1/3)
102.GlaxoSmithKline Plc – Overview (2/3)
103.GlaxoSmithKline Plc – Overview (3/3)
104.GlaxoSmithKline Plc – Business segments
105.GlaxoSmithKline Plc – Key offerings
106.GlaxoSmithKline Plc – Key customers
107.GlaxoSmithKline Plc – Segment focus
108.Siemens Healthineers AG – Overview (1/3)
109.Siemens Healthineers AG – Overview (2/3)
110.Siemens Healthineers AG – Overview (3/3)
111.Siemens Healthineers AG – Business segments
112.Siemens Healthineers AG – Key offerings
113.Siemens Healthineers AG – Key customers
114.Siemens Healthineers AG – Segment focus
115.Thermo Fisher Scientific Inc. – Overview (1/3)
116.Thermo Fisher Scientific Inc. – Overview (2/3)
117.Thermo Fisher Scientific Inc. – Overview (3/3)
118.Thermo Fisher Scientific Inc. – Business segments
119.Thermo Fisher Scientific Inc. – Key offerings
120.Thermo Fisher Scientific Inc. – Key customers
121.Thermo Fisher Scientific Inc. – Segment focus
122.Currency conversion rates for US$
123.Research Methodology
124.Validation techniques employed for market sizing
125.Information sources
126.List of abbreviations



【掲載企業】

Abbott Laboratories,Abcam Plc,Avantor Inc.,bioMerieux SA,Bio-Rad Laboratories Inc.,Danaher Corp.,Eppendorf AG,GlaxoSmithKline Plc,Siemens Healthineers AG,Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[酵素結合免疫吸着法(ELISA)の世界市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆